Delamanid for multidrug-resistant pulmonary tuberculosis
MT Gler, V Skripconoka… - … England Journal of …, 2012 - Mass Medical Soc
Background Delamanid (OPC-67683), a nitro-dihydro-imidazooxazole derivative, is a new
antituberculosis medication that inhibits mycolic acid synthesis and has shown potent in vitro …
antituberculosis medication that inhibits mycolic acid synthesis and has shown potent in vitro …
[引用][C] Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
MT Gler, V Skripconoka, E Sanchez-Garavito… - New England Journal …, 2012 - cir.nii.ac.jp
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
Delamanid for multidrug-resistant pulmonary tuberculosis.
MT Gler, V Skripconoka… - The New England …, 2012 - europepmc.org
Background Delamanid (OPC-67683), a nitro-dihydro-imidazooxazole derivative, is a new
antituberculosis medication that inhibits mycolic acid synthesis and has shown potent in vitro …
antituberculosis medication that inhibits mycolic acid synthesis and has shown potent in vitro …
Delamanid for multidrug-resistant pulmonary tuberculosis.
MT Gler, V Skripconoka, E Sanchez-Garavito… - 2012 - cabidigitallibrary.org
Abstract BACKGROUND: Delamanid (OPC-67683), a nitro-dihydro-imidazooxazole
derivative, is a new anti-tuberculosis medication that inhibits mycolic acid synthesis and has …
derivative, is a new anti-tuberculosis medication that inhibits mycolic acid synthesis and has …
Delamanid for multidrug-resistant pulmonary tuberculosis
MT Gler, V Skripconoka, E Sanchez-Garavito, H Xiao… - 2012 - pubmed.ncbi.nlm.nih.gov
Background Delamanid (OPC-67683), a nitro-dihydro-imidazooxazole derivative, is a new
antituberculosis medication that inhibits mycolic acid synthesis and has shown potent in vitro …
antituberculosis medication that inhibits mycolic acid synthesis and has shown potent in vitro …
[引用][C] Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
M TARCELA GLER, V SKRIPCONOKA… - The New England …, 2012 - pascal-francis.inist.fr
Author TARCELA GLER, Maria 1 2; SKRIPCONOKA, Vija 3; GEE YOUNG SUH 12;
DANILOVITS, Manfred 14; OGATA, Hideo 16; KURVE, Anu 15; CHANG, Joon 13; SUZUKI …
DANILOVITS, Manfred 14; OGATA, Hideo 16; KURVE, Anu 15; CHANG, Joon 13; SUZUKI …
[PDF][PDF] Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
MT Gler, V Skripconoka… - N Engl J Med, 2012 - academia.edu
ABSTRACT From the Makati Medical Center, Manila (MTG), and the Tropical Disease
Foundation, Makati City (MTG, TT)—both in the Philippines; the State Agency of …
Foundation, Makati City (MTG, TT)—both in the Philippines; the State Agency of …
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
MT Gler, V Skripconoka… - NEW ENGLAND …, 2012 - scholarworks.bwise.kr
BACKGROUND Delamanid (OPC-67683), a nitro-dihydro-imidazooxazole derivative, is a
new anti-tuberculosis medication that inhibits mycolic acid synthesis and has shown potent …
new anti-tuberculosis medication that inhibits mycolic acid synthesis and has shown potent …
[PDF][PDF] Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
MT Gler, V Skripconoka… - N Engl J …, 2012 - researchgate.net
ABSTRACT From the Makati Medical Center, Manila (MTG), and the Tropical Disease
Foundation, Makati City (MTG, TT)—both in the Philippines; the State Agency of …
Foundation, Makati City (MTG, TT)—both in the Philippines; the State Agency of …
[PDF][PDF] Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
MT Gler, V Skripconoka… - N Engl J Med, 2012 - core.ac.uk
ABSTRACT From the Makati Medical Center, Manila (MTG), and the Tropical Disease
Foundation, Makati City (MTG, TT)—both in the Philippines; the State Agency of …
Foundation, Makati City (MTG, TT)—both in the Philippines; the State Agency of …